Time to question long-term safety of routine scheduled inhaled beta-2-agonist treatment for COPD.
McCrory
Douglas C
DC
D000280:Administration, Inhalation; D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage* / Q000009:adverse effects*; D004334:Drug Administration Schedule; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000473:pathology; D013995:Time
D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists